smooth rock formations

IDAC Support

1 minute read

Published: April 6th, 2021

Phastar was awarded as a preferred supplier to a top 20 pharmaceutical sponsor, supporting five new studies per year. Each study was several years in length, with IDMC meetings taking place every 3-6 months. Phastar worked with this pharmaceutical sponsor through two models for IDAC support; model one offering independent programming of the blinded and unblinded IDMC package, with model two utilising sponsor programming code to produce blinded and unblinded IDMC package.

Complete the form below to read the full case study

Related articles

Translating Real-World Data into Commercial Success with Outcome Modelling 

Translating Real-World Data into Commercial Success with Outcome Modelling 

July 13th, 2026 1 minute read

Demonstrating real-world value is critical for securing pricing and market access, but bridging the gap between clini...

Scaling Real-World Evidence to Maximize Drug Lifecycle Value 

Scaling Real-World Evidence to Maximize Drug Lifecycle Value 

July 13th, 2026 1 minute read

Biopharma organizations have access to vast amounts of real-world data, but extracting meaningful, actionable insight...

Extending Trial Value with Long-Term Benefit–Risk Simulation in Prostate Cancer

Extending Trial Value with Long-Term Benefit–Risk Simulation in Prostate Cancer

July 13th, 2026 1 minute read

Demonstrating short-term efficacy is no longer enough, regulators increasingly require a clear understanding of long-...